Hypoandrogenism in association with diminished functional ovarian reserve

Human Reproduction

Volumn 28, Issue 4, 2013, Pages 1084-1091

  Gleicher, Norbert ^a,b   Kim, Ann ^a   Weghofer, Andrea ^a,c   Kushnir, Vitaly A ^a   Shohat Tal, Aya ^a   Lazzaroni, Emanuela ^a   Lee, Ho Joon ^a   Barad, David H ^a,b  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

androgens; fragile X mental retardation 1 (FMR1) gene; ovarian reserve; testosterone

Indexed keywords

FOLLITROPIN; FRAGILE X MENTAL RETARDATION PROTEIN; HYDROCORTISONE; MUELLERIAN INHIBITING FACTOR; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ANDROGEN DEFICIENCY; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARIAN RESERVE; OVARY INSUFFICIENCY; PREMATURE OVARIAN AGING; PREMATURE OVARIAN FAILURE; PROTEIN EXPRESSION;

EID: 84875599219     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det033     Document Type: Article

References (31)

1. Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974; 39: 340-346.
2. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007; 109: 1404-1410.
3. Barad DH, Weghofer A, Gleicher N. Utility of age-specific serum anti- Müllerian hormone concentrations. Reprod BioMedicine Online 2011; 22: 284-291.
4. Barbieri RL, Sluss PM, Powers RD, McShane PM, Vitonis A, Ginsburg E, Cramer DC. Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization. Fertil Steril 2005; 83: 302-308.
5. Baroni SS, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, Fraticelli P, Sambo P, Funaro A, Kazlauskas A et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354: 2667-2676.
6. Burger HG. Androgen production in women. Fertil Steril 2002; 77 (Suppl. 4): S3-5.
7. Butts SF, Seifer DB. Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril 2010; 93: 681-690.
8. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor ovarian response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011; 26: 1616-1624.
9. Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 2011; 66: 248-254.
10. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011; 9: 67.
11. Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmune Rev 2007; 7: 42-45.
12. Gleicher N, Weghofer A, Oktay K, Barad D. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)? Hum Reprod 2009; 24: 2395-2400.
13. Gleicher N, Weghofer A, Barad DH. Discordance between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility. Reprod Biol Endocrinol 2010a; 8: 64.
14. Gleicher N, Weghofer A, Lee IH, Barad DH. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS ONE 2010b; 5: e15303.
15. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 2011a; 9: 23.
16. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod Biol Endocrinol 2011b; 9: 116.
17. Gleicher N, Weghofer A, Lee IH, Barad DH. Association of FMR1 genotypes with in vitro fertilization)(VF) outcomes based on ethnicity/ race. PLoS ONE 2011c; 6: e18781.
18. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee H-J, Barad DH. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet 2013; 30: 49-62.
19. Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol Reprod 2011; 85: 431-441.
20. Horton R, Tait JF. Androstenedione production and interconversio rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest 1966; 45: 301-313.
21. Kelkar RL, Meherji PK, Kadam SS, Gupta SK, Nandedkar TD. Circulation auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol 2005; 66: 53-67.
22. Kevenaar ME, Meerasahib MF, Kramer P, van de lang-Born BM, de Jong FH, Groome NP, Themmen AP, Visser JA. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 2006; 147: 3228-3234.
23. Ledger W. Clinical utility of measurements of anti-Müllerian hormone in reproductive endocrinology. J Clin Endocinol Metab 2010; 95: 5144-5154.
24. Longcope C. Adrenal and gonadal androgen secretion in normal females. J Clin Endocrinol Metab 1986; 15: 213-228.
25. Lytton SD, Kahaly GJ. Bioassays for TSH-receptor -autoantibodies: an update. Autoimmune Rev 2010; 10: 116-122.
26. Nelson LM. Clinical Practice. Primary ovarian insufficiency. N Engl J Med 2009; 360: 606-614.
27. NOT-OD-01-053. NIH policy on reporting race and ethnicity data: subjects in clinical research. http://www.grants.nih.gov/grants/guide/notice-files/not- od-01-053.html (20 October 2012, date last accessed).
28. Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS. Adrenal androgenproduction capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 1973-1978.
29. Sen A, Hammes SR. Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 2010; 24: 1393-1403.
30. Speroff L, Glass RH, Kase NG. Clinical Gynecology Endocrinology and Infertility, 5th Ed. Baltimore, MA: Williams & Wilkins, 1994.
31. Weghofer A, Kim A, Barad DH, Gleicher N. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation. Hum Reprod 2012; 27: 3287-3293.